BioSpace News Archive

Rubedo Life Sciences today announced the selection of the first-in-class development candidate RLS-1496 for the treatment of dermatological conditions using its ALEMBIC™ drug discovery platform at LSX World Conference 2023.

Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced interim data from the Phase 2 portion of the open-label Phase 1/2 study of single-agent eltanexor in patients with higher R/R myelodysplastic neoplasms.

CNS Pharmaceuticals, Inc. announced that it is investigating potential naked short selling of its stock and has retained well-known analytics firm, Shareholder Intelligence Services, LLC, to review the trading patterns of the Company’s common stock.

Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders, announced today their participation at the Clinical TMS Society Annual Meeting in Colorado Springs, CO on May 4th – 6th.

Volpara Health Technologies Ltd. (ASX: VHT), a global leader in software for the early detection of cancer, is attending the 2023 Society of Breast Imaging annual symposium, May 4-7 in Maryland.

AOM Infusion, a leading specialty infusion provider focused on intravenous immunoglobulin, chronic inflammatory and specialty infusion therapy, announced that Keyur Mehta has been named Chief Executive Officer.

The Insight Partners published latest research report on “Small Molecule Drug Discovery Market Size Report, Share, Growth & Trends Forecast to 2027 - COVID-19 Impact and Global Analysis by Therapeutic Area; Process/Phase; and Geography”,

New analyses from a large retrospective validation study of early lung cancer metabolomics panel, underscoring strength of BioMark’s liquid biopsy platform, to be presented.

BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) is pleased to announce that VINIA®, the first product developed on its proprietary Bio-Plant CELLicitation platform, has been recognized as an Honorable mention in the Wellness category of Fast Company’s 2023 World Changing Ideas Awards.

RaySearch Laboratories AB announces that New York University Langone Hospital - Long Island in Mineola, New York, has placed an order for the treatment planning system RayStation®*.